ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Fighting Heartburn and Gerd Naturally – And Safely!

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Natural Bladder Control, Go Less and Live More

Top Vitamin and Mineral Deficiencies — Are You at Risk?

Trimming the spare tire: Canola oil may cut belly fat

How Pomegranate May Protect Against Cancer

Omega Fix for Obesity: How the Right Fats Fight Fat

Curcumin Reverses the Cellular Damage of Chronic Stress

The Onion: Cancer Fighter and Food Preserver

Probiotics improve cognition in Alzheimer's patients

 
Print Page
Email Article

Slides of Ampligen® Trial Results Used in Presentation at IACFS/ME Conference

  [ 2 votes ]   [ Discuss This Article ]
www.ProHealth.com • March 19, 2009


Ampligen® is an investigational, intravenously delivered drug that has been tested in clinical trials involving ‘chronic fatigue syndrome’ (ME/CFS) patients for years. It is classified as a toll-like receptor (TLR) activator, which means its mode of action would be as an agent that activates TLRs to induce immune cell responses to pathogens.

Ampligen’s maker, Hemispherx Biopharma (HB), awaits the FDA’s decision on its New Drug Application, due May 25. And recently HB's Medical Director, Dr. David Strayer, presented the latest trial findings at the 2009 IACFS/ME Conference (Mar 12-15) in Reno. The trial involved patients treated at 12 clinical sites in the U.S.

You can now click through the slides Dr. Strayer used in this presentation, at HB’s website (www.hemispherx.net). (At the same time you will hear audio, not linked to the slides, from a webcast the company held Thursday Mar 19 to discuss its year-end 2008 results.) You’ll have a choice of versions employing Windows Media Player or RealPlayer.

The Title of the Slide Presentation:
“Interferon and Cytokine Levels in a Double-blind, Randomized, Placebo-controlled Phase III Clinical trial (AMP-516) of Poly I: Poly C12U (Ampligen®) in CFS.”

Authors: Strayer DR, Stouch BC, Horvath JC, Stevens SR, Carter WA. Hemispherx Biopharma Inc., Philadelphia, Pennsylvania; University of the Pacific, Stockton, California.

Investigators at the 12 sites: Drs. Bateman, Bellesorte, Cimoch, John, Keller, Lapp, Mercandetti, Peterson, Papernick, Podell, Stein, Taylor.

A Few Notes:
• Trial subjects were diagnosed with CFS, duration at least 12 months, and fell between 40 and 60 on the Karnofsky scale of functional impairment.

• Ampligen (or placebo) was delivered via IV infusions lasting about 30 minutes, twice weekly for 40 weeks.

Measured results included:
- Treadmill test of peak exercise duration
- Change from initial use of concomitant medications related to CFS

Mean (average) results for exercise duration (change from baseline to week 40):
- For those receiving Ampligen - improvement from 576 seconds to 672 seconds.
- For those receiving placebo – improvement from 588 seconds to 616 seconds.

More specifically, the mean percent of subjects who improved exercise duration:
- At least 25% - was 39% with Ampligen, vs. 23% with placebo
- At least 50% - was 26% with Ampligen, vs. 14% with placebo

Decrease in use of medications (decrease in number of days individual medications were taken during weeks 36-40 of study vs weeks 1-4):
- 72% of Ampligen group reduced medication use, vs. 56% of placebo group
- 26% of Ampligen group did not decrease med use, vs. 44% of placebo group

* * * *

Visit www.hemispherx.net for more detail.




Post a Comment

Featured Products From the ProHealth Store
Mitochondria Ignite™ with NT Factor® FibroSleep™ Ultra EPA  - Fish Oil


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Secret Nutrient for Radiant Skin Secret Nutrient for Radiant Skin
Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery
Reversing Neurodegeneration with a New Magnesium Compound Reversing Neurodegeneration with a New Magnesium Compound
The Curcumin Revolution: 'Golden' Ticket to Better Health The Curcumin Revolution: 'Golden' Ticket to Better Health
Could a B-12 Deficiency Be Causing Your Symptoms? Could a B-12 Deficiency Be Causing Your Symptoms?

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map